Study reveals potential new strategy for managing inflammatory bowel disease
Celltrion unveils promising dose escalation results for subcutaneous infliximab
Related Posts
Vivan renews five-year lease at UK biotech hub White City Place
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics has signed a new five-year lease at White […]
Positive results for MAIA’s SCLC treatment published in Nature Communications
The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide MAIA Biotechnology has announced that positive results from its preclinical studies […]
NHS launches new campaign to help patients get treatment from pharmacies
Pharmacy First will enable patients to receive treatment for seven common conditions The NHS has launched a new campaign to raise awareness of the seven […]